Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...
Editor’s note: Previous versions of the simulation were incorrectly calculating each team’s odds of reaching the conference finals and beyond. That error has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results